Annual Non Current Assets
$685.25 M
+$114.74 M+20.11%
31 December 2023
Summary:
Sarepta Therapeutics annual long term assets is currently $685.25 million, with the most recent change of +$114.74 million (+20.11%) on 31 December 2023. During the last 3 years, it has risen by +$185.72 million (+37.18%). SRPT annual non current assets is now at all-time high.SRPT Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$914.57 M
+$173.94 M+23.49%
30 September 2024
Summary:
Sarepta Therapeutics quarterly long term assets is currently $914.57 million, with the most recent change of +$173.94 million (+23.49%) on 30 September 2024. Over the past year, it has increased by +$255.71 million (+38.81%). SRPT quarterly non current assets is now at all-time high.SRPT Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.1% | +38.8% |
| 3 y3 years | +37.2% | +91.8% |
| 5 y5 years | +217.4% | +168.8% |
SRPT Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +37.2% | at high | +91.8% |
| 5 y | 5 years | at high | +217.4% | at high | +168.8% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Sarepta Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $914.57 M(+23.5%) |
| June 2024 | - | $740.62 M(-2.5%) |
| Mar 2024 | - | $759.52 M(+10.8%) |
| Dec 2023 | $2.58 B(+0.8%) | $685.25 M(+4.0%) |
| Sept 2023 | - | $658.86 M(+0.9%) |
| June 2023 | - | $653.28 M(+14.3%) |
| Mar 2023 | - | $571.41 M(+0.2%) |
| Dec 2022 | $2.56 B(-1.8%) | $570.50 M(+7.6%) |
| Sept 2022 | - | $530.22 M(+0.5%) |
| June 2022 | - | $527.55 M(+0.4%) |
| Mar 2022 | - | $525.21 M(-3.4%) |
| Dec 2021 | $2.60 B(+4.8%) | $543.88 M(+14.0%) |
| Sept 2021 | - | $476.91 M(-3.4%) |
| June 2021 | - | $493.86 M(-0.0%) |
| Mar 2021 | - | $493.88 M(-1.1%) |
| Dec 2020 | $2.49 B(+69.2%) | $499.52 M(+9.1%) |
| Sept 2020 | - | $457.99 M(+8.1%) |
| June 2020 | - | $423.62 M(+5.9%) |
| Mar 2020 | - | $400.04 M(+13.0%) |
| Dec 2019 | $1.47 B(+3.0%) | $353.91 M(+4.0%) |
| Sept 2019 | - | $340.17 M(+6.2%) |
| June 2019 | - | $320.33 M(+9.5%) |
| Mar 2019 | - | $292.47 M(+35.5%) |
| Dec 2018 | $1.43 B(+16.1%) | $215.89 M(+26.4%) |
| Sept 2018 | - | $170.83 M(+58.3%) |
| June 2018 | - | $107.92 M(+33.5%) |
| Mar 2018 | - | $80.87 M(+1.9%) |
| Dec 2017 | $1.23 B(+229.0%) | $79.32 M(+22.6%) |
| Sept 2017 | - | $64.67 M(+8.6%) |
| June 2017 | - | $59.55 M(+9.8%) |
| Mar 2017 | - | $54.23 M(+7.1%) |
| Dec 2016 | $373.48 M(+66.3%) | $50.63 M(-3.7%) |
| Sept 2016 | - | $52.57 M(+3.3%) |
| June 2016 | - | $50.87 M(-3.4%) |
| Mar 2016 | - | $52.64 M(+6.9%) |
| Dec 2015 | $224.54 M(-9.4%) | $49.24 M(-21.4%) |
| Sept 2015 | - | $62.64 M(+27.0%) |
| June 2015 | - | $49.32 M(-0.7%) |
| Mar 2015 | - | $49.66 M(+5.1%) |
| Dec 2014 | $247.80 M(-8.5%) | $47.24 M(-4.1%) |
| Sept 2014 | - | $49.24 M(+50.9%) |
| June 2014 | - | $32.64 M(+25.4%) |
| Mar 2014 | - | $26.02 M(+25.3%) |
| Dec 2013 | $270.81 M(+39.7%) | $20.76 M(+47.7%) |
| Sept 2013 | - | $14.06 M(+31.0%) |
| June 2013 | - | $10.73 M(-35.9%) |
| Mar 2013 | - | $16.75 M(+51.1%) |
| Dec 2012 | $193.91 M(+329.2%) | $11.09 M(+1.5%) |
| Sept 2012 | - | $10.92 M(+23.2%) |
| June 2012 | - | $8.87 M(-1.6%) |
| Mar 2012 | - | $9.02 M(-1.8%) |
| Dec 2011 | $45.18 M(+19.4%) | $9.18 M(+0.5%) |
| Sept 2011 | - | $9.14 M(+2.6%) |
| June 2011 | - | $8.91 M(+4.4%) |
| Mar 2011 | - | $8.54 M(+4.9%) |
| Dec 2010 | $37.84 M | $8.14 M(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $8.55 M(-2.2%) |
| June 2010 | - | $8.73 M(+0.7%) |
| Mar 2010 | - | $8.68 M(-0.5%) |
| Dec 2009 | $51.31 M(+201.0%) | $8.72 M(+6.6%) |
| Sept 2009 | - | $8.18 M(-1.4%) |
| June 2009 | - | $8.29 M(+0.6%) |
| Mar 2009 | - | $8.24 M(-3.0%) |
| Dec 2008 | $17.04 M(-40.6%) | $8.49 M(-13.8%) |
| Sept 2008 | - | $9.86 M(-1.8%) |
| June 2008 | - | $10.03 M(-0.8%) |
| Mar 2008 | - | $10.12 M(+1.9%) |
| Dec 2007 | $28.71 M(-15.4%) | $9.93 M(-1.8%) |
| Sept 2007 | - | $10.11 M(+1.2%) |
| June 2007 | - | $9.99 M(+42.8%) |
| Mar 2007 | - | $7.00 M(+1.1%) |
| Dec 2006 | $33.94 M(-30.2%) | $6.92 M(-4.5%) |
| Sept 2006 | - | $7.25 M(-0.4%) |
| June 2006 | - | $7.28 M(-0.9%) |
| Mar 2006 | - | $7.35 M(-5.2%) |
| Dec 2005 | $48.65 M(+140.9%) | $7.75 M(-3.3%) |
| Sept 2005 | - | $8.02 M(-1.2%) |
| June 2005 | - | $8.11 M(-1.4%) |
| Mar 2005 | - | $8.22 M(-1.2%) |
| Dec 2004 | $20.20 M(-47.4%) | $8.32 M(-2.9%) |
| Sept 2004 | - | $8.57 M(+0.9%) |
| June 2004 | - | $8.49 M(-1.7%) |
| Mar 2004 | - | $8.64 M(-1.3%) |
| Dec 2003 | $38.39 M(+88.2%) | $8.75 M(-0.5%) |
| Sept 2003 | - | $8.80 M(-0.5%) |
| June 2003 | - | $8.85 M(+1.1%) |
| Mar 2003 | - | $8.75 M(+6.7%) |
| Dec 2002 | $20.40 M(-25.8%) | $8.20 M(+6.3%) |
| Sept 2002 | - | $7.71 M(+6.2%) |
| June 2002 | - | $7.27 M(+3.3%) |
| Mar 2002 | - | $7.04 M(+11.6%) |
| Dec 2001 | $27.51 M(-17.0%) | $6.30 M(+45.9%) |
| Sept 2001 | - | $4.32 M(+23.0%) |
| June 2001 | - | $3.51 M(+17.9%) |
| Mar 2001 | - | $2.98 M(+52.2%) |
| Dec 2000 | $33.13 M(+183.2%) | $1.96 M(+12.1%) |
| Sept 2000 | - | $1.75 M(-4.6%) |
| June 2000 | - | $1.83 M(+34.3%) |
| Mar 2000 | - | $1.36 M(+13.5%) |
| Dec 1999 | $11.70 M(+30.0%) | $1.20 M(-7.7%) |
| Sept 1999 | - | $1.30 M(0.0%) |
| June 1999 | - | $1.30 M(0.0%) |
| Mar 1999 | - | $1.30 M(+8.3%) |
| Dec 1998 | $9.00 M(-49.2%) | $1.20 M(+9.1%) |
| Sept 1998 | - | $1.10 M(-15.4%) |
| June 1998 | - | $1.30 M(+8.3%) |
| Mar 1998 | - | $1.20 M(+9.1%) |
| Dec 1997 | $17.70 M(+490.0%) | $1.10 M(+22.2%) |
| Sept 1997 | - | $900.00 K(0.0%) |
| June 1997 | - | $900.00 K(-35.7%) |
| Mar 1997 | - | $1.40 M |
| Dec 1996 | $3.00 M | - |
FAQ
- What is Sarepta Therapeutics annual long term assets?
- What is the all time high annual non current assets for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual non current assets year-on-year change?
- What is Sarepta Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly non current assets year-on-year change?
What is Sarepta Therapeutics annual long term assets?
The current annual non current assets of SRPT is $685.25 M
What is the all time high annual non current assets for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual long term assets is $685.25 M
What is Sarepta Therapeutics annual non current assets year-on-year change?
Over the past year, SRPT annual long term assets has changed by +$114.74 M (+20.11%)
What is Sarepta Therapeutics quarterly long term assets?
The current quarterly non current assets of SRPT is $914.57 M
What is the all time high quarterly non current assets for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly long term assets is $914.57 M
What is Sarepta Therapeutics quarterly non current assets year-on-year change?
Over the past year, SRPT quarterly long term assets has changed by +$255.71 M (+38.81%)